Today: 4 April 2026
Why Almonty Industries (ALM) stock slid Friday — and what matters before Monday
11 January 2026
1 min read

Why Almonty Industries (ALM) stock slid Friday — and what matters before Monday

Toronto, January 10, 2026, 21:22 (EST) — Market closed

Almonty Industries Inc’s shares on the U.S. market dropped 7.3% Friday, finishing at $8.63. The stock swung between $8.38 and $9.37, with roughly 3.7 million shares changing hands before bouncing back to $8.82 in after-hours trading. StockAnalysis

The move followed the expiration of a short lock-up tied to December financing, introducing new supply pressure on the stock. A lock-up prevents certain holders from selling shares for a defined period after a deal; S&P Capital IQ data cited by MarketScreener showed the restriction ran from Dec. 9 to Jan. 8, covering options, equity-linked instruments, and common shares. MarketScreener

The timing is key because the December deal stood out compared to Almonty’s usual trading volume. The company sold 20.7 million common shares at $6.25 each, pulling in $129.375 million before fees. BofA Securities led the underwriting. Almonty plans to channel the cash into multiple projects. CEO Lewis Black said the firm is “fully capitalized” to carry out its exploration and expansion plans. Business Wire

Almonty’s shares in Toronto slipped 6.8% to close at C$12.00 Friday, hitting a low of C$11.65 during the session. Trading volume reached roughly 714,000 shares. StockAnalysis

Commodity sentiment plays a role here, though Friday’s moves appeared mainly driven by stock-specific factors. Almonty’s website notes its tungsten pricing data comes from FastMarkets and gets updated every Friday. The company points out that tungsten pricing often refers to ammonium paratungstate (APT), a key chemical benchmark for the metal. Almonty Industries

The selling forced investors to weigh two opposing signals. Almonty’s recent financing provided fresh capital, yet lifting selling restrictions can still weigh on the stock if holders choose to cash out.

There’s a clear downside risk: if more stock hits the market than buyers can handle at current prices. Just a few days of steady selling could overwhelm a small, volatile miner.

Traders are eyeing ownership and insider disclosures that could surface after the lock-up expires, alongside block prints signaling major holders unloading. Volume will reveal the story.

Almonty positions itself as a tungsten supplier with both operating assets and development projects. Still, the market often revalues these companies fast whenever the funding environment changes. Securing cash doesn’t erase execution risk.

Markets in the U.S. and Canada reopen Monday, Jan. 12. Investors will watch closely to see if Friday’s sell-off spills over or eases after the weekend break.

Stock Market Today

  • Morgan Stanley's Growing Wealth Management and SpaceX IPO Buzz May Shift Bull Case
    April 3, 2026, 6:01 PM EDT. Morgan Stanley is gaining traction as a fee-rich wealth and investment manager, surpassing $1 trillion in IRA assets and $9.3 trillion in total client assets. The bank's potential lead retail role in the SpaceX IPO via E*TRADE could reinforce its long-term retirement investment strategy and boost recurring fee revenue. Despite optimistic forecasts projecting $76 billion in revenue by 2028, analysts differ on Morgan Stanley's future earnings potential amid increasing digital competition and regulatory risks. The evolving narrative centers on balancing growth in wealth management with challenges in capital markets and wealth margin pressures. Investors should watch how these factors shape Morgan Stanley's valuation and strategic direction moving forward.
Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next
Previous Story

Merit Medical stock slides 7% after board shake-up and early Q4 revenue range — what to watch next

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next
Next Story

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Go toTop